PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
PT Kalbe Farma Total Assets (Quarterly): 1.824B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.824B |
December 31, 2023 | 1.732B |
September 30, 2023 | 1.767B |
June 30, 2023 | 1.810B |
March 31, 2023 | 1.892B |
December 31, 2022 | 1.743B |
September 30, 2022 | 1.728B |
June 30, 2022 | 1.693B |
March 31, 2022 | 1.880B |
December 31, 2021 | 1.797B |
September 30, 2021 | 1.674B |
June 30, 2021 | 1.592B |
March 31, 2021 | 1.627B |
December 31, 2020 | 1.580B |
September 30, 2020 | 1.504B |
June 30, 2020 | 1.546B |
March 31, 2020 | 1.527B |
December 31, 2019 | 1.459B |
September 30, 2019 | 1.372B |
June 30, 2019 | 1.336B |
March 31, 2019 | 1.342B |
December 31, 2018 | 1.252B |
September 30, 2018 | 1.175B |
June 30, 2018 | 1.235B |
March 31, 2018 | 1.263B |
Date | Value |
---|---|
December 31, 2017 | 1.230B |
September 30, 2017 | 1.201B |
June 30, 2017 | 1.233B |
March 31, 2017 | 1.194B |
December 31, 2016 | 1.127B |
September 30, 2016 | 1.131B |
June 30, 2016 | 1.081B |
March 31, 2016 | 1.083B |
December 31, 2015 | 986.14M |
September 30, 2015 | 901.64M |
June 30, 2015 | 954.27M |
March 31, 2015 | 989.51M |
December 31, 2014 | 995.14M |
September 30, 2014 | 985.46M |
June 30, 2014 | 1.023B |
March 31, 2014 | 1.023B |
December 31, 2013 | 928.19M |
September 30, 2013 | 898.85M |
June 30, 2013 | 1.087B |
March 31, 2013 | 1.014B |
December 31, 2012 | 970.05M |
September 30, 2012 | 909.51M |
June 30, 2012 | 968.96M |
March 31, 2012 | 947.88M |
December 31, 2011 | 901.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.336B
Minimum
Jun 2019
1.892B
Maximum
Mar 2023
1.654B
Average
1.684B
Median
Total Assets (Quarterly) Benchmarks
Taihe Group Inc | 0.00 |
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 19.38M |
IGC Pharma Inc | 11.26M |
NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 305.45M |
Shareholders Equity (Quarterly) | 1.410B |
Debt to Equity Ratio | 0.0295 |
Current Ratio | 4.313 |
Net Debt Paydown Yield | 0.14% |